Healthcare · Pharmaceutical expenditure

Pharmaceutical expenditure in Norway in 2026

Norway is among the world leaders in pharmaceutical expenditure — 2.50 % GDP of GDP in 2026. This high figure stems not from inefficiency but from costly innovative drugs actively procured for the healthcare system and harsh climatic conditions requiring special logistics for delivering medicines to Arctic regions. The country ranks 3 out of 197 nations.

Data for 2026 · unit: % GDP
Position

Norway world ranking

#3 / 197

Country position on the scale from last to first place for this indicator.

NO
#3
#197#1
Trend

Change over time

Change in indicator over the available period.

1.20
1990
1.80
2000
2.10
2010
2.40
2020
2.50
2026

Values — % GDP

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical expenditure in Norway — how much?
Based on 2026 data — 2.50 % GDP. This is rank #3 out of 197 countries.
What is Norway's rank by Pharmaceutical expenditure?
Norway ranks #3 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Norway?
Over the available period the indicator changed from 1.20 to 2.50 % GDP.